GPCR News

Blog: Blog2

Dr. GPCR News

Aug 145 min read

GPCR Weekly News

Competitive vs Non-Competitive GPCR Antagonists: How to Interpret Pharmacology Data with Confidence

Dr. GPCR Podcast

Aug 122 min read

Podcast Highlights

Decoding Olfactory GPCRs: How AlphaFold and AI Are Changing the Game

Dr. GPCR Podcast

Aug 72 min read

Podcast Highlights

From Venice to Virtual Molecules: Alessandro Nicoli’s Unexpected Journey into Computational Chemistry

Terry's Desk

Jul 293 min read

Terry's Corner

GPCR Allosteric Modulation: Why Allostery is the Engine of Drug Discovery

Dr. GPCR News

Jul 244 min read

Dr. GPCR News

Why Kinetics Matter More Than Kd in GPCR Drug Discovery

Terry's Desk

Jul 223 min read

Terry's Corner

How Fast Does a Drug Work?

Dr. GPCR News

Jul 174 min read

Dr. GPCR News

Your GPCR Program Decisions Depend on Good Data Interpretation

Terry's Desk

Jul 152 min read

Terry's Corner

Breaking the Myth of High and Low Affinity Sites

GPCR News

Aug 1, 20221 min read

GPCR Papers

SYnAbs is now officially accredited as a Research Tax Credit by the French Ministry of Higher...

GPCR News

Jul 1, 20221 min read

GPCR Papers

Exscientia is 10 years old this July!

GPCR News

Jul 1, 20221 min read

GPCR Papers

Orion and Peptilogics are pursuing AI-driven drug discovery to explore new functional chemical ...

GPCR News

Feb 1, 20221 min read

GPCR Papers

InterAx Biotech AG and Boehringer Ingelheim take collaborate to unlock orphan targets leveraging ...

February 2022 "InterAx Biotech AG and Boehringer Ingelheim take first steps towards collaborating to unlock orphan targets leveraging...

GPCR News

Dec 1, 20211 min read

GPCR Papers

OMass Therapeutics's founder, Carol Robinson, has been awarded the prestigious Louis-Jeantet ...

December 2021 OMass Therapeutics's founder, Carol Robinson, has been awarded the prestigious Louis-Jeantet Prize for Medicine 2022 by the...

GPCR News

Competitive vs Non-Competitive GPCR Antagonists: How to Interpret Pharmacology Data with Confidence

Decoding Olfactory GPCRs: How AlphaFold and AI Are Changing the Game

From Venice to Virtual Molecules: Alessandro Nicoli’s Unexpected Journey into Computational Chemistry

GPCR Allosteric Modulation: Why Allostery is the Engine of Drug Discovery

Why Kinetics Matter More Than Kd in GPCR Drug Discovery

How Fast Does a Drug Work?

Your GPCR Program Decisions Depend on Good Data Interpretation

Breaking the Myth of High and Low Affinity Sites

SYnAbs is now officially accredited as a Research Tax Credit by the French Ministry of Higher...

Exscientia is 10 years old this July!

Orion and Peptilogics are pursuing AI-driven drug discovery to explore new functional chemical ...

InterAx Biotech AG and Boehringer Ingelheim take collaborate to unlock orphan targets leveraging ...

OMass Therapeutics's founder, Carol Robinson, has been awarded the prestigious Louis-Jeantet ...

Explore the Ecosystem

University

Foundry

Strategic Partners